Interestingly, antagonist-induced cellular senescence is counteracted by IL-23 treatment in C4-2 and 22Rv1 cells, both human CRPC cell lines, indicating that IL-23 interferes with AR signaling-mediated cellular senescence in PCa. The gene discussed is AR; the disease is posterior cortical atrophy.